Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non - Alcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03300661
What this trial is testing

Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine

Who this might be right for
Non Alcoholic Fatty Liver DiseaseLifestyleDiet Modification
Università degli Studi di Brescia 100
Not applicableStudy completedNCT04384159
What this trial is testing

Combination Diagnostic Strategies in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Liver Disease
University Hospital, Montpellier 577
Not applicableNot Yet RecruitingNCT07706010
What this trial is testing

Cardiovascular Risk in T2DM With MAFLD: A Cohort Study

Who this might be right for
Type 2 Diabetes (T2DM)Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Hospital of Hangzhou Normal University 7,000
Not applicableStudy completedNCT00641524
What this trial is testing

Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Western Ontario, Canada 45
Testing effectiveness (Phase 2)Study completedNCT06491576
What this trial is testing

A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
NASH
Burgeon Therapeutics Co., Ltd. 48
Post-approval studies (Phase 4)Looking for participantsNCT06989723
What this trial is testing

Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver
Seoul National University Bundang Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02496390
What this trial is testing

Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD

Who this might be right for
Diabetes MellitusNon-alcoholic Fatty Liver Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 21
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableUnknownNCT03534908
What this trial is testing

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study

Who this might be right for
NAFLDCardiovascular Diseases
Wuhan University 5,000,000
Early research (Phase 1)Looking for participantsNCT07726368
What this trial is testing

Study of ECC4703 With Sulfasalazine and Pitavastatin

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Dyslipidaemia
Eccogene 40
Not applicableStudy completedNCT02787668
What this trial is testing

A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity

Who this might be right for
Non-alcoholic Fatty Liver DiseaseChildhood ObesityInsulin Resistance
University of Alabama at Birmingham 27
Not applicableUnknownNCT05855239
What this trial is testing

Quantification of Hepatic Steatosis With Different Ultrasound Frequency

Who this might be right for
Fatty LiverFatty Liver, NonalcoholicUltrasound
Jong Keon Jang 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06005012
What this trial is testing

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Who this might be right for
Fibrosis, LiverType 2 Diabetes Mellitus in ObeseNon-Alcoholic Fatty Liver Disease
University of California, San Diego 120
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableActive Not RecruitingNCT05607745
What this trial is testing

Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study

Who this might be right for
NAFLDFecal MicrobiotaGut Microbiota+6 more
University of Eastern Finland 54
Not applicableNot Yet RecruitingNCT07716995
What this trial is testing

Association Between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaMetabolic Dysfunction-Associated Steatotic Liver Disease
Assiut University 127
Not applicableStudy completedNCT00262964
What this trial is testing

Obesity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Washington University School of Medicine 51
Not applicableStudy completedNCT02728765
What this trial is testing

Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Obstructive Sleep ApneaNon-alcoholic Fatty Liver Disease
Chinese University of Hong Kong 120
Not applicableLooking for participantsNCT05890365
What this trial is testing

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLow Birth Weight
Steno Diabetes Center Copenhagen 300
Large-scale testing (Phase 3)Study completedNCT06309992
What this trial is testing

Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Who this might be right for
ObesityNon-Alcoholic SteatoHepatitis (NASH)
Boehringer Ingelheim 218
Next Page